Literature DB >> 12758190

From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift.

Jim Yong Kim1, Joia S Mukherjee, Michael L Rich, Kedar Mate, Jaime Bayona, Mercedes C Becerra.   

Abstract

This review examines the paradigm shift around multidrug-resistant tuberculosis (MDR-TB). This shift has centered largely on the activities of institutions participating in the World Health Organization's Working Group on DOTS-Plus for MDR-TB. We review the important milestones since 1995, namely, the emergence of new evidence, the construction of new mechanisms, and the building of consensus to support new policy guidelines. This paper offers a case study of the construction of a model of good global governance that--if the opportunity is taken--can improve access to effective TB care through improving and helping to expand the WHO-recommended DOTS strategy.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12758190     DOI： 10.1016/s1472-9792(02)00078-1

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN： 1472-9792            Impact factor:   3.131


  9 in total

1.  Tuberculosis control: challenges of an ancient and ongoing epidemic.

Authors:  Kristin J Cummings
Journal:  Public Health Rep       Date:  2007 Sep-Oct       Impact factor: 2.792

2.  Implementation validation performed in Rwanda to determine whether the INNO-LiPA Rif.TB line probe assay can be used for detection of multidrug-resistant Mycobacterium tuberculosis in low-resource countries.

Authors:  Cindy Maria Quezada; Eliane Kamanzi; Julienne Mukamutara; Pim De Rijk; Leen Rigouts; Françoise Portaels; Yanis Ben Amor
Journal:  J Clin Microbiol       Date:  2007-07-11       Impact factor: 5.948

3.  Analysis of Green Light Committee implementation and acquisition of second-line drug resistance.

Authors:  John Z Metcalfe; Eric Vittinghoff; Philip C Hopewell
Journal:  Clin Infect Dis       Date:  2014-12-19       Impact factor: 9.079

4.  Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South Africa.

Authors:  Niaz Banaiee; Vanessa January; Charmaine Barthus; Maureen Lambrick; Denise Roditi; Marcel A Behr; William R Jacobs; Lafras M Steyn
Journal:  Tuberculosis (Edinb)       Date:  2007-11-05       Impact factor: 3.131

5.  Cardiovascular disease and global health equity: lessons from tuberculosis control then and now.

Authors:  Gene Bukhman; Alice Kidder
Journal:  Am J Public Health       Date:  2007-11-29       Impact factor: 9.308

6.  Study of Genetic Evolution in Mycobacterium tuberculosis Isolates from Patients with Active Pulmonary Tuberculosis in the Iran and Belarus.

Authors:  Saeed Zaker Bostanabad; Mehdi Shekarabei; Seyed Ali Nojoumi; Esmaeil Jabbarzadeh; Mostafa Ghalami; Vahid Molla Kazemi; Mostafa Gholi Beigdeli; Mohammad Karim Rahimi; Mohammad Bossak; Evgeni Romanovich Sagalchyk; Larisa Konstantina Surkova; Aksana Mikhaelovna Zalutska; Veronika Slizen; Leonid Petrovich Titov
Journal:  Open Microbiol J       Date:  2011-07-04

7.  Characterization of Molecular Evolution in Multi-Drug Resistant of Mycobacterium tuberculosis by rpoB Gene in Patient with Active Pulmonary Tuberculosis from Iranian Isolates.

Authors:  Zaker Bostanabad Saeed; Rahimi Mohammad Karim; Adimi Parvaneh; Tayebee Zahra; Masoumi Mozhgan; Pourazar Shahin; Jabbarzadeh Esmail; Shekarabi Mehdi; Pourmand Azarmidokht; Sourkova Larisa Konstantina; Titov Leonid Petrovich
Journal:  Int J Biomed Sci       Date:  2009-12

8.  Randomized trials to optimize treatment of multidrug-resistant tuberculosis.

Authors:  Carole D Mitnick; Kenneth G Castro; Mark Harrington; Leonard V Sacks; William Burman
Journal:  PLoS Med       Date:  2007-11-06       Impact factor: 11.069

9.  [Risk factors for multidrug-resistant tuberculosis in the city of Kinshasa in the Democratic Republic of Congo].

Authors:  André Misombo-Kalabela; Georges Nguefack-Tsague; Ginette Claude Mireille Kalla; Emmanuel Afane Ze; Kimpanga Diangs; Tshapenda Panda; Ilunga Kebela; Serge Bisuta Fueza; Nzanzu Magazani; François-Xavier Mbopi-Kéou
Journal:  Pan Afr Med J       Date:  2016-04-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.